Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)

HKG:2315 Revenue

Biocytogen Pharmaceuticals (Beijing) had revenue of 620.96M CNY in the half year ending June 30, 2025, with 89.99% growth. This brings the company's revenue in the last twelve months to 1.19B, up 48.76% year-over-year. In the year 2024, Biocytogen Pharmaceuticals (Beijing) had annual revenue of 980.45M with 36.76% growth.

• Revenue (ttm): 1.19B CNY
• Revenue Growth: +48.76%
• P/S Ratio: 9.79
• Revenue / Employee: 1.07M CNY
• Employees: 1,117
• Market Cap: 12.78B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	980.45M	263.54M	36.76%
Dec 31, 2023	716.91M	183.03M	34.28%
Dec 31, 2022	533.88M	179.33M	50.58%
Dec 31, 2021	354.56M	101.01M	39.84%
Dec 31, 2020	253.54M	-	-